DMCC Speciality Chemicals Ltd Q2 FY21 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- The company expects growth driven by expansion into specialty chemicals, including pharmaceuticals, agrochemicals, pigments, dyes, paints, and coatings sectors.
- New and existing products, especially in specialty chemicals, are anticipated to scale up with increased traction, despite slower-than-expected initial growth due to COVID-related delays.
- Domestic and overseas markets have returned to pre-COVID normalcy, with reasonable demand and operating revenues.
- Planned debottlenecking at Roha will expand production of specialty products, adding to specialty revenue without drastically changing sulfuric acid sales.
- Long-term demand for sulfones (thermal paper coatings) is expected to return once normal activities (stadiums, cinemas, airlines) resume.
- Capex investments aim for roughly 2x revenue from new plants, with a mix of dedicated and multipurpose facilities.
- New projects expected to be commercial and improve cash flows and return ratios fully by FY23, assuming no disruptions.
- Overall, growth is driven by product expansion, capacity utilization, and targeted investments in higher-value specialty chemicals.
See what DMCC Speciality Chemicals Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
Yes- The company is undertaking its largest-ever capex, with multiple projects extending up to December next year.
- They plan to fund the capex using roughly a 2:1 debt-to-equity ratio.
- Around ₹70 crore of loan is anticipated for this capex.
- Interest rate on loans could be around 4-5% if converted to foreign currency loans; otherwise, 9-10% in Indian Rupees.
- No specific mention of new equity fundraising; focus is on debt financing combined with equity.
- The company emphasizes they are not extensively extending equity, aiming to maintain reasonable return on equity.
- Management is confident about achieving planned cash flows from ongoing projects.
See what DMCC Speciality Chemicals Ltd management said on order book — free account, 30 seconds.
Capex plans
Yes- Ongoing and upcoming capex includes expansion of specialty chemicals, intermediates for pharma and agrochemicals, and bulk chemicals.
- Large investment at Dahej to create a second site similar in size to the Roha plant, including multipurpose and dedicated plants.
- Capex includes a 50 crore investment in a sulphuric acid plant supporting both internal consumption (50%) and external sales (50%).
- Additional investments include about 10 crore for two multipurpose plants (total), 20 crore in recently developed intermediate products, and debottlenecking to expand production at Roha.
- The capex is the largest in the company's history, estimated to generate approximately 200 crore in revenue per 100 crore investment once plants run at full capacity.
- Planned maintenance shutdown and restructuring have impacted recent operations; new investments signal a strategic growth phase.
- Financing planned at a ~2:1 debt-to-equity ratio; options include foreign currency loans at 4-5% or INR loans at 9-10%.
- Continued R&D investments for globally competitive processes and development of new products are ongoing.
Track DMCC Speciality Chemicals Ltd — get its next earnings analysis in your feed
Margin guidance
Category 3- Company expects growth driven by ramp-up of existing specialty chemical products and new dedicated plants.
- Domestic and international markets showing signs of returning to pre-COVID levels, supporting revenue growth.
- Expansion capex aimed at specialty intermediates and custom synthesis with planned investments at Roha and Dahej sites.
- Anticipated 2x revenue generation from new intermediate projects with similar margin profiles as sulfones.
- Bulk chemical margins expected to remain lower than specialty chemical margins; overall gross margins stable.
- Growth in mature products expected if market normalcy continues.
- No major new investments planned in bulk chemicals beyond current projects; focus on specialty chemicals.
- Profitability may improve as new plants stabilize and optimize production.
- External uncertainties remain (pandemic waves, commodity price fluctuations) which can impact near-term outlook.
Order book
How does DMCC Speciality Chemicals Ltd rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does DMCC Speciality Chemicals Ltd rank in Chemicals & Petrochemicals?
Compare DMCC Speciality Chemicals Ltd against every Chemicals & Petrochemicals company (Q2 FY21) on revenue, margins and earnings-call signals.
Continue your research
What DMCC Speciality Chemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Ch. (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
- Deepak Fertilis. (Q1 FY27)
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…